ArticleThe World Allergy Organization journal2025
Identification of three novel mite allergens, Der f 42, Der f 43, and Der f 44, from
Article in The World Allergy Organization journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: House dust mites (HDMs) produce major inhaled allergens that trigger allergic diseases worldwide. The identities of the full spectrum of HDM allergenic components are not yet known. We aimed to develop a new gelsolin interactome-analysis (GIA) method for discovering and identifying novel allergens. Methods: Gelsolin-binding proteins (GBPs) in Results: A total of 14 GBPs were assayed, including 10 known allergens and 4 candidates. Three candidates bound recombinant gelsolin, and they were named Der f 42, Der f 43, and Der f 44 by the WHO/IUIS Allergen Nomenclature Sub-committee. IgE-binding assays showed that Der f 42, Der f 43, and Der f 44 had IgE-binding rates of 7.2% (9/125), 8.5% (12/143), and 6.7% (6/90), respectively. Conclusion: GIA revealed 3 novel HDM proteins in this study and represents a new strategy for discovering and studying allergens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.